Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

927 results about "Tumor targeting" patented technology

Tumor targeting: Specific interaction between drug and its receptor at the molecular level. A rapidly growing tumor requires various nutrients and vitamins. Therefore, tumor cells over express many tumor-specific receptors which can be used as targets to deliver cytotoxic agents into tumors.

Individual mutation information-based intelligent decision-making system for precise targeted medication of tumors

The invention relates to the technical field of tumor treatment, in particular to an intelligent decision-making system for tumor precise targeted medication based on individual mutation information, which comprises a data processing layer, a variation annotation and function prediction layer, a knowledge base integration layer and a scheme decision-making engine and report visualization module. According to the intelligent decision-making system for tumor precise targeted medication based on individual mutation information, a rule engine and a prediction model are combined, dynamic priority ranking is output, multi-model fusion decision making is achieved, and clinical scene deep adaptation is achieved by predicting primary and secondary drug resistance, calculating liver and kidney function adjusting dosage and generating a combined medication time sequence scheme; through an individualized drug delivery scheme, combination drug use optimization is achieved, a visual clinical report is generated, clinical executable operation is further strengthened, and through algorithm quantification, a dynamic knowledge graph, AI auxiliary decision making and a clinical operation closed loop, the next-generation technical research direction of a tumor precise drug use system can be represented.
Owner:BEIJING BIOMASION TECH

Compound DOTA-HX2-DZ and application thereof

The invention provides a compound DOTA-HX2-DZ and application thereof, and belongs to the technical field of biological medicine. According to the invention, the molecular structure of DZ-HX2-DOTA is optimized, and a special connexon is designed and adopted, so that the problem of limited anti-tumor curative effect caused by poorer stability, fat solubility, tumor residence time and other properties of a radiolabeled drug in the prior art is solved. The compound provided by the invention can significantly reduce the risk of label removal of radioactive metal ions in an in-vivo environment, and ensures that the compound stably plays a role at a targeted part; the compound has excellent molecular lipid solubility, can penetrate cell membranes and vascular barriers more easily, improves the bioavailability of drugs, prolongs the in-vivo circulation time, prolongs the tumor residence time, and further improves the treatment efficiency. The DZ-HX2-DOTA disclosed by the invention has broad-spectrum tumor targeting property, and can be used for diagnosing and treating various types of malignant tumors.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV

AIE type fluorescent probe with tumor targeting property as well as preparation and application of AIE type fluorescent probe

The invention discloses an AIE type fluorescent probe with tumor targeting as well as preparation and application thereof, and belongs to the technical field of medicines, the probe can accurately target HDAC6 high-expression tumor cells, the specific binding capacity of the probe reduces interference to normal cells, and the detection accuracy is improved. The probe is fused with AIE performance dye molecules and emits strong fluorescence during aggregation, so that the imaging sensitivity and definition are remarkably enhanced. By optimizing the structure and synthesis conditions, the fluorescence intensity and stability of the probe are improved, the sensitivity of early tumor detection is ensured, and the survival rate and life quality of patients are improved. The preparation method is simple, convenient, feasible, low in cost and beneficial to practical application. The probe can be used for preparing tumor detection products, assisting in tumor diagnosis and classification, monitoring treatment changes and evaluating the curative effect. High-precision imaging can be realized in the aspect of tumor imaging, the method can be used for evaluating curative effect and guiding formulation of subsequent treatment schemes, and the application prospect is wide.
Owner:XIDIAN UNIV

BiTE for tumor targeted immunotherapy as well as preparation method and application of BiTE

The invention provides BiTE for tumor targeted immunotherapy and a preparation method and application, and relates to the technical field of biological pharmacy, the BiTE is obtained by coupling a nano antibody and fusion protein, the C terminal of the nano antibody contains an amino acid sequence SEQ ID No.3, and the BiTE has the function of targeting a human epidermal growth factor receptor on tumor cells; the fusion protein also targets a CD3 receptor on a T cell, activates the T cell, connects the T cell with a tumor cell in time and space, activates the T cell, secretes perforin and granzyme B to kill the tumor cell, and plays a role in targeted immunotherapy. The isopeptide bond is used for coupling the nano antibody and the fusion protein, coupling can be completed within 15 min, the coupling efficiency is 100%, and the in-vivo half-life period of the nano antibody can be prolonged by 6 times.
Owner:JILIN UNIVERSITY

Nano photosensitizer modified by outer membrane vesicles of genetically engineered bacteria as well as preparation method and application of nano photosensitizer

The invention provides a nano photosensitizer modified by outer membrane vesicles of genetically engineered bacteria as well as a preparation method and application of the nano photosensitizer. The nano photosensitizer is a nano material with the particle size of 80-120 nm, and the nano photosensitizer modified by the genetically engineered bacterium outer membrane vesicle comprises dipalmitic acid phosphatidylcholine (DPPC), distearoyl phosphatidylcholine (DSPC), dioleoyl lecithin (DOPC), cholesterol, a small molecule dye and CD47nb-OMV membrane protein. The chemical structure of the small molecule dye is shown as a formula I or a formula II. The nano photosensitizer OBDlp modified by outer membrane vesicles of genetically engineered bacteria serves as a novel nano photosensitizer, tumor targeting PTT is mediated through NIR II FL / PA imaging, tumor immunogenicity is improved, antigen presenting cells are activated, and infiltration and functionalization of CD8 + T cells are caused. And OBDlp and laser are combined to induce release of a large amount of DAMPs and trigger ICD to promote maturation of cDC1s. Meanwhile, a CD47 nano antibody carried by the nano photosensitizer induces polarization of M1 phenotype macrophages by blocking a CD47-SIRP alpha signal transduction axis, and an immunosuppression tumor microenvironment is reversed.
Owner:GUANGDONG YUNZHAO MEDICAL TECH CO LTD

Dual payload antibody drug conjugates for the treatment of cancer

The present invention relates to an antibody-drug conjugate (ADC) comprising as a first payload a cytotoxic molecule and as a second payload a tumor-targeting small molecule for use in the treatment of cancer, wherein the cancer is characterized by the presence of a cancer cell comprising a first antigen that is specifically bound by an antibody portion of the ADC and a second antigen that specifically interacts with the tumor-targeting small molecule.
Owner:ARARIS BIOTECH AG

Enzyme response type KRAS targeted protein degradation chimera as well as preparation method and application thereof

The invention discloses an enzyme response type KRAS targeted protein degradation chimera as well as a preparation method and application thereof, and belongs to the technical field of tumor targeted therapy. The enzyme response type KRAS targeted protein degradation chimera disclosed by the invention is obtained by covalently linking three parts, namely a KRAS targeted protein degradation chimera, an enzyme response type amino acid sequence and a cell penetrating peptide amino acid sequence, wherein the KRAS targeted protein degradation chimera is obtained by linking a KRAS targeted peptide and a VHL E3 ligase ligand through succinic acid. The enzyme response type KRAS targeted protein degradation chimera releases the KRAS targeted protein degradation chimera under the action of ATG4 enzyme shearing, and shows a relatively strong lung cancer resisting effect in vitro and in vivo. The invention has significant advantages in the aspect of antitumor drugs, and opens up a new field for the development of targeted protein degradation chimera drugs. Enzyme response type KRAS targeted protein degradation chimera molecular structural formula as follows: # imgabs0 #
Owner:YANTAI UNIV

Polypeptide for targeted blocking of combination of TRIM25 and BRD7 protein and application thereof

The invention belongs to the field of biomedicine, and particularly relates to polypeptide for targeted blocking of combination of TRIM25 and BRD7 protein and application of the polypeptide. According to the present invention, based on the minimum binding region PRYSPRY structural domain (439 aa-630 aa) of the TRIM25 and the BRD7 protein, the blocking peptide TB16 capable of specifically blocking the mutual binding of the TRIM25 and the BRD7 protein is screened, such that the ubiquitination degradation of the BRD7 is inhibited, and the stability of the BRD7 tumor inhibition protein is improved. The polypeptide drug TB16 can effectively inhibit breast cancer, nasopharynx cancer, ovarian cancer, lung cancer and liver cancer cell proliferation and breast cancer in-vivo tumor growth, has good anti-solid tumor activity, and is expected to become a new anti-tumor targeting drug.
Owner:CENT SOUTH UNIV

Polyethylene Glycol Modified Zwitterionic Fluorescent Probe and Application Thereof, and Preparation

The present disclosure is a polyethylene glycol modified zwitterionic fluorescent probe. The core luminescent group of the fluorescent probe of the present disclosure is a heptamethine chain which is connected by a phenoxy bridge and has a rigid ring structure in the center. The two ends of the heptamethine chain are two sulfonic indole groups, and two polyethylene glycol chains are connected with the indole groups. A tumor targeting ligand is connected with a luminescent group through one polyethylene glycol chain and one alkaline amino acid spacer. The probe of the present disclosure can be connected with polypeptides, small molecules and antibodies having a tumor targeting function, thereby achieving near-infrared fluorescence imaging for tumor targeting. The probe of the present disclosure has good druggability, and is extremely suitable for industrial production and clinical promotion.
Owner:BEIJING SONOPHOTONANO MEDICAL TECHNOLOGY CO LTD

Preparation method and application of CD70 specific nano antibody molecular imaging probe

The invention provides a preparation method and application of a CD70 specific nano antibody molecular imaging probe. The probe comprises a tumor targeting group, radionuclide and a bifunctional chelating agent, the tumor targeting group is a CD70 specific nano antibody; the CD70 specific nano antibody is R8B4, and the amino acid sequence of the R8B4 is as shown in SEQ ID No. 1. The probe provided by the invention can realize noninvasive diagnosis of solid tumors such as renal clear cell carcinoma and malignant tumors of a blood system; reabsorption of the compound in the kidney is effectively inhibited through charge adjustment, kidney uptake is remarkably reduced, non-specific signals are reduced, the signal-to-noise ratio during targeted imaging or treatment is increased, and the imaging quality and treatment safety are improved. The probe not only has a wide application prospect in tumor diagnosis, but also provides a new technical support for targeted therapy and individualized precision medical treatment, and has important scientific research and clinical application values.
Owner:RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE

Ecteinascidin compound and use thereof

Disclosed in the present invention are an ecteinascidin compound and the use thereof. Provided in the present invention is a compound as represented by formula (I), or a pharmaceutically acceptable salt, an ester, a stereoisomer, a tautomer, a polymorph, a solvate, an isotopically labeled compound, a metabolite or a prodrug thereof. The compounds provided by the present invention have one or more effects selected from the following group: (1) having an inhibitory activity against tumor cell proliferation in vitro; (2) having a tumor inhibition effect in vivo; (3) having an in vivo tumor targeting capability; and (4) having good safety in vivo.
Owner:DUALITY BIOLOGICS (SUZHOU) CO LTD

Preparation method and application of preparation based on platelet targeting oncolytic virus delivery

The invention provides a preparation method and application of a platelet-based targeting oncolytic virus delivery preparation, effective loading of oncolytic viruses is realized by infecting platelets with the oncolytic viruses, and meanwhile, the cellular structure of the platelets can be used as a physical barrier, so that the platelet-based targeting oncolytic virus delivery preparation is prepared. The tumor targeting drug delivery system shields the neutralizing and removing effects of in-vivo neutralizing antibodies / complements / removing cells on the oncolytic viruses, so that the oncolytic viruses can enter the body in a systematic drug delivery mode, tumor targeting drug delivery of the oncolytic viruses is achieved through the tumor targeting capacity of platelets, and the success of intravenous drug delivery and tumor targeting of the oncolytic viruses is achieved. The invention provides a technical support and a new idea for wider and more effective treatment of cancers, and has a good application prospect.
Owner:ZHEJIANG UNIV +1

AuAgPt ternary alloy nano-frame, preparation method thereof and application of AuAgPt ternary alloy nano-frame in anti-tumor preparation

The invention discloses an AuAgPt ternary alloy nano-framework, a preparation method thereof and application of the AuAgPt ternary alloy nano-framework in anti-tumor preparations, and belongs to the field of biomedical nano-materials. The AuAgPt ternary alloy nano frame is a hollow octahedral nano frame formed by 12 AuAgPt ternary alloy edges, and the nano frame has plasmon photothermal conversion performance, catalase activity and peroxidase-like activity, and can be used for preparing the nano frame. The aptamer has the characteristics that the aptamer can form a covalent bond with glutathione (GSH), the aptamer with the framework surface capable of being modified and specifically bound with tumor cells is used for tumor targeted delivery and the like, the aptamer can be bound in a targeted manner and internalized into the tumor cells, and after near-infrared laser irradiation, the cell temperature can be increased to 42 DEG C, reactive oxygen species (ROS) can be generated, GSH can be consumed, and the tumor targeting effect is achieved. In addition, the content change of small molecule metabolites in cells can be driven through a low-temperature photothermal effect, the metabolic state is disturbed, the redox balance in the cells is destroyed, the tumor cells are induced to generate ferroptosis and apoptosis, and the low-temperature photothermal treatment of tumors is realized.
Owner:CENT SOUTH UNIV

Tumor targeting reagent and application thereof in tumor diagnosis

The invention discloses a tumor targeting reagent and application thereof in tumor diagnosis. The targeting reagent has strong affinity to tumors, strong specificity and no biotoxicity, is relatively stable in vivo, and can be used as a molecular probe to be applied to molecular imaging and / or treatment of various integrin alpha6 high-expression tumors; the targeting reagent provided by the invention comprises the tumor targeting peptide RWYDeA, and further comprises a radionuclide chelating agent, other connecting structures and a hydroxyl substitution structure, and the structure is beneficial to improving the tumor targeting property of the targeting reagent, prolonging the tumor binding time and achieving a better tumor diagnosis effect; the method can be used for preparing products for diagnosing / treating diseases related to high expression of integrin alpha6.
Owner:GUANGZHOU GENBIONOVA MEDICAL TECH CO LTD

Polypeptide-based PROTAC condensation body and preparation method and application thereof

The invention discloses a polypeptide-based PROTAC condensation body as well as a preparation method and application of the polypeptide-based PROTAC condensation body. The polypeptide-based PROTAC aggregate comprises an HER2 (human epidermal growth factor receptor) targeting module, an EGFR (epidermal growth factor receptor) targeting module, a VHL E3 ligase targeting module and a self-assembly module. The polypeptide-based PROTAC condensation body can dynamically enrich E3 ligase VHL and promote efficient ubiquitination degradation of HER2, EGFR and downstream signal channel protein of HER2 and EGFR, the degradation efficiency of HER2 and EGFR protein can reach 92%, the degradation efficiency of downstream signal channel protein such as SOS2 and RAS can reach 80%, and in addition, the polypeptide-based PROTAC condensation body has the advantages that the polypeptide-based PROTAC condensation body can be used as an efficient ubiquitination condensation body; the polypeptide-based PROTAC condensation body has the characteristics of tumor targeting and long-acting retention, and dose-dependent tumor specific accumulation and retention can be realized through in-situ self-assembly.
Owner:THE NAT CENT FOR NANOSCI & TECH NCNST OF CHINA

Multifunctional nano-enzyme as well as preparation method and application thereof

The invention discloses a multifunctional nano-enzyme as well as a preparation method and application thereof, and belongs to the technical field of nano-enzyme synthesis. Aiming at the problems that a traditional nano-enzyme is single in activity, limited in treatment effect, poor in tumor active targeting specificity and the like, the multifunctional nano-enzyme provided by the invention is simple and efficient in preparation method, and is prepared by taking N and P double-doped hollow carbon nanospheres as a carrier, loading L-arginine and glucose oxidase and taking an aptamer as a targeting molecule. The multifunctional nano-enzyme is small in particle size, high in dispersion degree and good in biological safety. The multifunctional nano-enzyme not only has the activities of peroxidase, nitric oxide synthase and glucose oxidase, but also has excellent photo-thermal conversion capacity in tumor targeted therapy. The multifunctional nano-enzyme provided by the invention has a tumor focus specific recognition capability, can be highly enriched at a tumor part, finally realizes the purpose of photothermal / catalytic treatment combined tumor treatment, and provides a new thought and platform for tumor treatment.
Owner:SHANXI DATONG UNIV

Manganese-enriched albumin boron-containing nano preparation as well as preparation method and application thereof

The invention discloses a manganese-enriched albumin boron-containing nano preparation as well as a preparation method and application thereof, and belongs to the field of medicines and nano biological materials. According to the manganese-enriched albumin boron-containing nano preparation, albumin serves as a core carrier, phenylboronic acid derivatives are loaded through covalent or electrostatic interaction, then a manganese oxide layer is deposited on the surface in situ, and the prepared manganese-enriched albumin boron-containing nano preparation can remarkably increase the boron accumulation amount in tumor tissue; local and systemic immune response of tumors is promoted through the immune activation effect of manganese ions, so that the treatment effect of boron neutron capture therapy (BNCT) is remarkably improved. According to the invention, a phenylboronic acid derivative with tumor targeting is compounded with albumin, and manganese oxide is deposited in situ on the surface of the phenylboronic acid derivative, so that a multifunctional nano preparation with high boron delivery efficiency, immunological enhancement and magnetic resonance imaging functions is formed.
Owner:ZHEJIANG UNIV

Dual-targeting macrophage membrane nano system as well as preparation method and application thereof

The invention discloses a dual-targeting macrophage membrane nano system and a preparation method and application thereof, and belongs to the field of biological medicine, MKA is wrapped in a macrophage membrane after AuNPs and mitochondrial targeting peptide KLA are connected. The preparation method comprises the following steps: firstly synthesizing AuNPs and modifying, and then wrapping with a macrophage membrane. In treatment, the compound can realize double targeting of tumor cells and mitochondria, enhance radiation-induced DNA damage, inhibit DDR, activate immune pathways and promote T cell infiltration, and can also consume glutathione and amplify oxidative stress to enhance immune effect, and the dose enhancement ratio of the compound in cooperation with 8GyX-rays reaches 3.1. In addition, the MKA is good in biocompatibility in vivo, long in blood circulation time, high in tumor targeting and capable of being quickly cleared through the kidney. The invention provides a new way for tumor radioimmunotherapy, and is helpful for promoting the progress of clinical tumor treatment.
Owner:ANHUI PROVINCIAL HOSPITAL

Method for detecting hypoxia condition in noninvasive solid tumor

The invention relates to a noninvasive solid tumor internal hypoxia condition detection method, which comprises: chemically modifying a near-infrared two-region fluorophore, an oxygen sensitive group and a tumor targeting group to construct a composite probe, collecting fluorescence and photoacoustic signals of a tumor region after intravenous injection, carrying out de-noising analysis, and combining with multiple parameters to solve hypoxia concentration change, a four-dimensional space-time distribution map is constructed by fusing vascular topological data, and individualized calibration is realized through microfluidic simulation and Bayesian optimization. Compared with a traditional invasive detection and single-mode imaging technology, the advantages of bimodal signals are integrated in a breakthrough mode, non-invasive, real-time and high-resolution dynamic hypoxia monitoring is achieved, acute and chronic hypoxia areas are accurately distinguished, tumor blood vessel heterogeneity interference is reduced through personalized parameter calibration, and the accuracy of hypoxia monitoring is improved. High-precision spatio-temporal data support based on hypoxia microenvironment monitoring is provided for solid tumor radiotherapy target planning, chemotherapy drug delivery optimization, chemotherapy drug resistance and curative effect prediction and evaluation and tumor metastasis progress risk analysis.
Owner:CHINESE PEOPLES LIBERATION ARMY XINJIANG MILITARY REGION GENERAL HOSPITAL

Methods and reagents for tumor targeting with greater efficacy and less toxicity

The present invention relates to a method for treating cancer. This method involves providing a first agent comprising a first targeting component coupled to a first cancer therapeutic component and providing a second agent comprising a second targeting component coupled to a second cancer therapeutic component. The first and second targeting components have different biodistributions and / or pharmacokinetics. The first and second agents are administered to a subject having cancer to treat the cancer. Also disclosed is a combination therapeutic comprising the first and second agents.
Owner:CORNELL UNIVERSITY

Raman probe for detecting hydrogen sulfide as well as preparation method and application of Raman probe

The invention relates to a Raman probe for detecting hydrogen sulfide as well as a preparation method and application of the Raman probe. The gold and silver nanocage (AuAg NCs) is prepared, and after the gold and silver nanocage (AuAg NCs) is modified by a Raman signal molecule 4-ethynylaniline (4EA), it is found that the AuAg-4EANCs shows the strongest Raman enhancement effect at the position of 2010 cm <-1 > located in a cell silence zone. The SERS probe with the tumor targeting capability is developed through the functional modification of a mucoprotein 1 aptamer (MUin1aptamer, MUC1Apt) and polyethylene glycol (PEG), and the SERS probe with the tumor targeting capability is further developed through the functional modification of the mucoprotein 1 aptamer (MUin1aptamer, MUC1Apt) and the PEG (Polyethylene Glycol). In the presence of hydrogen sulfide (H2S) and oxygen, Ag in AuAg-4EANCs rapidly reacts with H2S to generate Ag2S with significantly reduced Raman enhancement performance, resulting in sharp attenuation of 4EA signal intensity. And along with the increase of the H2S concentration, the generation amount of Ag2S is increased, so that a quantitative detection model dependent on the H2S concentration is established.
Owner:JIANGNAN UNIV

Boron medicine with tumor targeted release capability for boron neutron capture therapy and preparation method thereof

The invention provides a boron drug with tumor targeted release capability for boron neutron capture therapy and a preparation method thereof, relates to the technical field of tumor therapy, and provides a boron drug which can be activated through high-concentration NAD (P) H at a tumor site and can release a B-10 drug in a targeted manner for boron neutron capture therapy. A boron-10-containing compound in the boron medicine is connected with 3-aldehyde quinoline salt through a self-elimination reactive group, the 3-aldehyde quinoline salt can be specifically reduced by NAD (P) H rich in tumor cells to trigger chain reaction, and the effective boron-10 compound is released for boron neutron capture therapy. The damage to normal cells in the BNCT process can be effectively reduced by a method for targeted aggregation of the boron drug in the tumor cells. The boron drug synthesis method is simple, mild in condition and high in yield, has the advantages of stable chemical property, good light stability, small toxicity and the like, and provides a good application prospect for the field of boron neutron capture therapy.
Owner:AFFILIATED HOSPITAL OF NANTONG UNIV +2

Conjugate of indocyanine green and multi-arm polyethylene glycol or pharmaceutically acceptable salt thereof as well as preparation method and application of conjugate

The invention relates to the technical field of tumor fluorescence contrast agents, and particularly provides a conjugate of indocyanine green and multi-arm polyethylene glycol or pharmaceutically acceptable salt of the conjugate and a preparation method and application of the conjugate, the conjugate has the structural formula shown in the formula (I), the binding capacity of the conjugate and serum protein is remarkably reduced, and the conjugate can be applied to tumor fluorescence contrast agents. According to the present invention, the tumor targeting property is significantly improved, and the tumor is accumulated and detained in the tumor tissue, such that the targeted treatment or the high-resolution imaging is achieved so as to achieve the accurate tumor positioning and diagnosis, the high application value is provided, and the new method is developed for the tumor imaging and the treatment.
Owner:NANJING YUNYING BIOTECHNOLOGY CO LTD

Application of anti-PTPRZ1 chimeric antigen receptor macrophage in lung cancer treatment

The invention relates to application of anti-PTPRZ1 chimeric antigen receptor macrophages in lung cancer treatment, and belongs to the technical field of tumor targeted therapy. The invention constructs a novel chimeric antigen receptor (CAR) which comprises a coding sequence of a single-chain variable region fragment for specifically recognizing PTPRZ1, and a coding sequence of a CD8TM transmembrane region and a coding sequence of a CD3zeta intracellular signal transduction structural domain. The design ingeniously endows the chimeric antigen receptor (CAR) with high specificity, so that the chimeric antigen receptor (CAR) can accurately recognize and firmly bind to the surface of a tumor cell expressing PTPRZ1 protein. According to the present invention, the chimeric antigen receptor targeting PTPRZ1 is successfully transfected into the human macrophage to form the CAR-M. A flow cytometry verifies that compared with non-transfected macrophages (Mphi) or transfected macrophages lacking a specific target binding domain (CAR-M-delta), the CAR-M has the advantage that the efficiency of swallowing PTPRZ1 positive tumor cells is remarkably improved in the aspect of the efficiency of swallowing PTPRZ1 positive tumor cells. Therefore, the CAR-M constructed by the invention can be used as a potential treatment means for targeting PTPRZ1 expression tumors.
Owner:THE FIRST AFFILIATED HOSPITAL OF ARMY MEDICAL UNIV

VEGFR-2 affinity peptide and application thereof

The invention belongs to the technical field of biological medicines, and discloses a VEGFR-2 affinity peptide and application thereof, the VEGFR-2 affinity peptide can target a vascular endothelial growth factor receptor VEGFR-2, so that the VEGFR-2 affinity peptide can carry out in-vivo diagnosis on tumors with high expression of the VEGFR-2 receptor, and therefore, the VEGFR-2 affinity peptide can be used for in-vivo diagnosis of tumors with high expression of the VEGFR-2 receptor. The VEGFR-2 affinity peptide provided by the invention can be applied to preparation of a novel tumor diagnostic reagent or a novel tumor targeted drug carrier.
Owner:CHINA PHARM UNIV

HER2 (human epidermal growth factor receptor 2) targeting antibody coupling gold (III) porphyrin medicine as well as synthesis and tumor treatment application of HER2 targeting antibody coupling gold (III) porphyrin medicine

The invention relates to an HER2 (human epidermal growth factor receptor 2) targeting antibody coupling gold (III) porphyrin medicine as well as a synthesis method and tumor treatment application thereof. The antibody coupling gold (III) porphyrin drug targeting HER2 is formed by connecting an anti-HER-2 trastuzumab and an A3B type gold (III) porphyrin complex through a linker, and the linker comprises a maleimide joint connected with an antibody and a self-elimination joint connected with the A3B type gold (III) porphyrin complex. The A3B type gold (III) porphyrin complex with anti-tumor activity is combined with trastuzumab with a specific recognition function as a carrier, the antibody is utilized to accurately strike tumor cells, a medicine is delivered to a tumor environment, the tumor targeting property of the gold (III) porphyrin complex is improved, and accurate treatment is realized. Distribution of drugs in the body can be improved, accumulation of the drugs in non-tumor sites can be reduced, the dosage of metal complexes is reduced, and toxic and side effects are reduced; the efficient delivery of gold drugs to tumor tissues can also be realized, and the cancer treatment effect is improved.
Owner:GAOBO PHARM CO LTD

Preparation and anti-tumor application of Ilisimu / copper-NLG919 bionic nanoparticles wrapped by tumor cell membranes

The invention discloses preparation and anti-tumor application of tumor cell membrane coated Ilisimus / copper-NLG919 bionic nanoparticles, and particularly relates to a bionic nano-drug which is characterized in that NLG919, ES and Cu < 2 + > are used as active ingredients to construct a self-assembled drug system (ECN), and meanwhile, a tumor cell membrane is used for coating the ECN to form ECNM; compared with a traditional EC, the built ECNM has the advantages that the systemic circulation stability, tumor targeting and tumor accumulation of the EC are remarkably improved, copper death and chemical kinetic therapy (CDT) can be efficiently triggered, a tumor immunosuppression microenvironment (TIM) can be synergistically reversed, and then a higher tumor immunotherapy effect is achieved. The nano-drug disclosed by the invention has good biological safety, cycling stability and homologous tumor targeting property, the preparation method is simple and convenient, and materials and equipment are easy to obtain.
Owner:SUQIAN FIRST PEOPLES HOSPITAL (JIANGSU PROVINCIAL PEOPLES HOSPITAL SUQIAN BRANCH)

Near-infrared small-molecule fluorescent dye with pentadecanedioic conjugated chain as well as preparation method and application of near-infrared small-molecule fluorescent dye

The invention relates to a near-infrared small-molecule fluorescent dye with a pentadecamethine conjugated chain and a preparation method and application thereof, the near-infrared small-molecule fluorescent dye has a structure as shown in a general formula A, and is a novel dye matrix based on two benzoindole structures connected by a pentadecamethine chain, the functional dye molecule with the absorption and emission peak wavelength in the near-infrared region is obtained through regulation and control of substituent groups on a parent structure, and different substituent groups can be introduced to a fifteen-membered methine chain and an indole N atom. The absorption and emission wavelength is in a near-infrared region of 1100-1300nm, and the material has the characteristics of high brightness, excellent light stability, low cytotoxicity, simplicity and convenience in synthesis, easiness in structure modification and the like. After water-soluble modification, the polymer can be widely applied to the biomedical fields of tumor targeting imaging, living body angiography and the like. General formula A # imgabs0 #
Owner:SHANGHAI JIAOTONG UNIV

Chimera for targeted degradation of GPX4 based on HSP70 protein as well as preparation method and application of chimera

The invention discloses a chimera for targeted degradation of GPX4 based on HSP70 protein as well as a preparation method and application of the chimera, and belongs to the technical field of biological medicines. According to the invention, 12 chimeras for targeted degradation of GPX4 are prepared by using the technology. The HSP70 molecular chaperone complex mediated protein targeted degradation chimera provided by the invention can rapidly and durably induce the degradation of GPX4. Meanwhile, the chimeras have obvious anti-proliferative activity on GPX4 high-expression cell strains and high-selectivity induction of ferroptosis of cells, and have important significance on tumor targeted therapy and drug resistance overcoming.
Owner:INSTITUTE OF BASIC MEDICINE & CANCER CHINESE ACADEMY OF SCIENCES (PREPARATORY)

Fusion protein as well as preparation method and application thereof

The invention belongs to the technical field of biological medicines, discloses a fusion protein as well as a preparation method and application thereof, and particularly discloses a fusion protein which comprises a DDX60 functional structural domain and a tumor-targeted cell-penetrating peptide. The invention provides a fusion protein, the fusion protein has tumor targeted cell penetrability and can activate anti-tumor immunity, and the fusion protein can directly send a DDX60 functional structure domain into tumor cells and maintain the stability of dsRNA; meanwhile, the protein can improve the sensitivity of other anti-tumor immunotherapies by activating the autoimmunity of a body, a new thought is provided for the development of anti-cancer targeted drugs, the efficiency and the application range of the existing anti-tumor immunotherapies are expanded, and the protein has important significance in tumor treatment.
Owner:SUN YAT SEN UNIVERSITY CANCER CENTER (CANCER HOSPITAL AFFILIATED TO SUN YAT SEN UNIVERSITY CANCER RESEARCH INSTITUTE OF SUN YAT SEN UNIVERSITY)